|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kun huei yeh"
Showing items 256-280 of 291 (12 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T04:46:20Z |
Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid
|
Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
|
Yeh, P.Y.;Chuang, S.-E.;Yeh, K.-H.;Song, Y.C.;Chang, L.L.-Y.;Cheng, A.-L.Yeh, Py;Chuang, Se;Kun-Huei, Yeh;Song, Yc;Chang, Ll;Cheng, Al.; KUN-HUEI YEH; Yeh, PY; Chuang, SE; ANN-LII CHENG; Kun-Huei, Yeh; Song, YC; Chang, LL; Cheng, AL. |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao, Y.;Yeh, K.H.;Chang, C.J.;Chen, L.T.;Chao, T.Y.;Wu, M.F.;Chang, C.S.;Chang, J.Y.;Chung, C.Y.;Kao, W.Y.;Hsieh, R.K.;Cheng, A.L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Lu, Y.-S. and Hsu, C. and Li, C.-C. and Kuo, S.-H. and Yeh, K.-H. and Yang, C.-H. and Hsu, C.-H. and Wu, C.-Y. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells
|
Yeh, K.-H.;Cheng, A.-L.;Wan, J.-P.;Lin, C.-S.;Liu, C.-C.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Panhypopituitarism caused by solitary parasellar metastasis from lung cancer
|
Ko, J.-C. and Yang, P.-C. and Huang, T.-S. and Yeh, K.-H. and Kuo, S.-H. and Luh, K.T.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:46:18Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C. and Shen, Y.-C. and Yang, C.-H. and Yeh, K.-H. and Lu, Y.-S. and Hsu, C.-H. and Liu, H.-T. and Li, C.-C. and Chen, J.-S. and Wu, C.-Y. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:46:18Z |
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation
|
Yeh, P.Y.;Yeh, K.-H.;Chuang, S.-E.;Song, Y.C.;Cheng, A.-L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:46:18Z |
Recent advances in therapy for gastric cancer
|
Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:44:15Z |
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas
|
Kuo, S.-H. and Chen, L.-T. and Yeh, K.-H. and Wu, M.-S. and Hsu, H.-C. and Yeh, P.-Y. and Mao, T.-L. and Chen, C.-L. and Doong, S.-L. and Lin, J.-T. and Cheng, A.-L.; Sung-Hsin Kuo; KUN-HUEI YEH; MING-SHIANG WU; SHIN-LIAN DOONG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:27:00Z |
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
|
Yeh, P.Y.;Chuang, S.-E.;Yeh, K.-H.;Song, Y.C.;Cheng, A.-L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:27:00Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Yeh, K.-H. and Lu, Y.-S. and Hsiao, C.-H. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:07:08Z |
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation
|
Yeh, P.Y.;Chuang, S.-E.;Yeh, K.-H.;Song, Y.C.;Ea, C.-K.;Cheng, A.-L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:07:08Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu, C.-H. and Cheng, A.-L. and Hsu, C. and Yang, C.-H. and Lu, Y.-S. and Lin, C.-C. and Bu, C.-F. and Yeh, K.-H.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T04:05:09Z |
High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
|
Liang, J.-T. and Huang, K.-C. and Lai, H.-S. and Lee, P.-H. and Cheng, Y.-M. and Hsu, H.-C. and Cheng, A.-L. and Hsu, C.-H. and Yeh, K.-H. and Wang, S.-M. and Tang, C. and Chang, K.-J.; PO-HUANG LEE; KUO-CHIN HUANG; Jin-Tung Liang; CHIH-HUNG HSU; HONG-SHIEE LAI; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T03:43:07Z |
The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E
|
KUN-HUEI YEH; Yeh, K.-H. and Kondo, T. and Zheng, J. and Tsvetkov, L.M. and Blair, J. and Zhang, H. |
| 臺大學術典藏 |
2018-09-10T03:43:07Z |
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin
|
KUN-HUEI YEH; ANN-LII CHENG; Yeh, P.Y.;Chuang, S.-E.;Yeh, K.-H.;Chyi Song, Y.;Cheng, A.-L. |
| 臺大學術典藏 |
2018-09-10T03:25:21Z |
Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil
|
Yeh, K.-H. and Yeh, S.-H. and Hsu, C.-H. and Wang, T.-M. and Ma, I.-F. and Cheng, A.-L.; KUN-HUEI YEH |
| 中國醫藥大學 |
2014-02 |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first?line chemotherapy in patients with locally advanced or metastatic gastric cancer.
|
(Yee Chao);(Jan-Sing Hsieh);(Hsien-Tang Yeh);(Yu-Chieh Su);(Cheng-Chung Wu);(Jen-Shi Chen);(Cheng-Jeng Tai);白禮源(Li-Yuan Bai);(Kun-Huei Yeh);(Wu-Chou Su);(Chung?Pin Li)* |
| 臺大學術典藏 |
2014 |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Chao, Y. and Hsieh, J.-S. and Yeh, H.-T. and Su, Y.-C. and Wu, C.-C. and Chen, J.-S. and Tai, C.-J. and Bai, L.-Y. and Yeh, K.-H. and Su, W.-C. and Li, C.-P.; KUN-HUEI YEH |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2005-10 |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
|
Lu, YS; Lien, HC; Yeh, PY; Kun-Huei, Yeh; Kuo, ML; Kuo, SH; Cheng, AL |
| 國立臺灣大學 |
2005-07 |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment.
|
Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Kun-Huei, Yeh; Yu, YC; Whang-Peng, J; Yang, PC. |
| 國立臺灣大學 |
2005-07 |
Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma.
|
Kuo, SH; Chen, LT; Chen, CL; Doong, SL; Kun-Huei, Yeh; Wu, MS; Mao, TL; Hsu, HC; Wang, HP; Lin, JT; Cheng, AL. |
Showing items 256-280 of 291 (12 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page
|
